Beneficial non-targeted effects of BCG—Ethical implications for the coming introduction of new TB vaccines
- 30 November 2006
- journal article
- review article
- Published by Elsevier in Tuberculosis
- Vol. 86 (6) , 397-403
- https://doi.org/10.1016/j.tube.2006.02.001
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Bacille Calmette-Guerin Vaccine--Induced Disease in HIV-Infected and HIV-Uninfected ChildrenClinical Infectious Diseases, 2006
- Inverse association between Mycobacterium tuberculosis infection and atopic rhinitis in childrenAllergy, 2005
- Childhood atopy and allergic disease and skin test responses to environmental mycobacteria in rural Crete: a cross‐sectional surveyClinical and Experimental Allergy, 2005
- Does childhood immunization against infectious diseases protect from the development of atopic disease?Pediatric Allergy and Immunology, 2005
- Lower prevalence of reported asthma in adolescents with symptoms of rhinitis that received neonatal BCGAllergy, 2004
- The effect of BCG vaccine at birth on the development of atopy or allergic disease in young childrenAnnals of Allergy, Asthma & Immunology, 2004
- The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: An historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic diseaseJournal of Allergy and Clinical Immunology, 2003
- Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination ScarringInfection and Immunity, 2002
- Delayed–type hypersensitivity skin testing in human immunodeficiency virus–infected pediatric patientsThe Journal of Pediatrics, 1996
- Bacillus Calmette—Guérin immunization in infants born to HIV-1-seropositive mothersAIDS, 1991